Google and Apple have a history of butting heads. (Remember the whole Google Maps/iOS 6 fiasco from last year?) Well, now leaders from the two tech giants are partnering to launch a new healthcare project named Calico, which will Google CEO Larry Page and Apple Chairman and former Google board member Arthur Levinson are working together on the healthcare startup, which will focus on end-of-life health issues.
Page announced the new startup venture on his Google Plus page on Wednesday morning:
“Art and I are excited about tackling aging and illness. These issues affect us all — from the decreased mobility and mental agility that comes with age, to life-threatening diseases that exact a terrible physical and emotional toll on individuals and families. And while this is clearly a longer-term bet, we believe we can make good progress within reasonable timescales with the right goals and the right people.”
Calico will embrace a growing trend in the medical field — the merger of healthcare with technology. Both Page and Levinson have a long history of success in the technology field and Levinson, who will run the new company, has some healthcare industry experience.
Levinson is the former chairman of Genentech, a biotechnology company that focuses on the development, manufacturing and marketing of medicine to treat serious and life-threatening illnesses. Unlike Genentech, Calico will concentrate solely on end-of-life and age-related diseases and conditions.
In his Google Plus announcement, Page says the project is still in its “early days so there’s not much more to share yet. Of course when Art has something more substantial to communicate (and that will likely take time), he’ll provide an update.” According to the Daily Mail, “In an interview with Time magazine, Page suggested it could take 10 to 20 years before Calico's efforts bear fruit.”
That is par for the course for the healthcare industry and although it will take time before we see any benefits from Calico, I’m excited about the project announcement. When you combine the technological expertise of Page with Levinson’s Genentech experience, you have the perfect set of ingredients for a successful healthcare venture.
via [Daily Mail Online]
Related on MNN: